Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Molecular Profile | FLT3 positive |
Therapy | CLN-049 |
Indication/Tumor Type | acute myeloid leukemia |
Response Type | predicted - sensitive |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FLT3 positive | acute myeloid leukemia | predicted - sensitive | CLN-049 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, CLN-049 decreased growth and increased survival in a cell line xenograft model of FLT3-positive acute myeloid leukemia (Cancer Res 2022;82(12_Suppl):Abstract nr 2078). | detail... |
PubMed Id | Reference Title | Details |
---|---|---|
CLN-049 is a bispecific T cell engaging IgG-like antibody targeting FLT3 on AML cells | Full reference... |